UNSPSC 41131512: Automated platelet aggregation system

In this classification, an automated platelet aggregation system is a device used to determine changes in platelet shape and platelet aggregation following the addition of an aggregating reagent to a platelet-rich plasma. US FDA regulates Automated platelet aggregation system under 21 CFR 864.5700 and under FDA product code JOZ.

UNSPSC 41131512 Automated platelet aggregation system is a Commodity code that encompasses laboratory hematology and blood chemistry instrumentation and consumables procured by state health agencies and higher-education institutions for clinical diagnostics, quality assurance, and screening applications. Recent state and local solicitations show state health departments and university laboratories acquiring hemoglobin testing analyzers with automated sample handling capability, proficiency testing samples for quality control, and specialized consumables such as ion-exchange columns, nebulizers, cones, filters, and reagent solutions for blood lead analysis and HbA1c screening. The Texas Health and Human Services Commission and Department of State Health Services have emerged as the primary recent issuing bodies, supplemented by University of Wisconsin-Madison procurement, indicating that state public-health laboratories and academic clinical facilities drive demand under this code.

Texas accounts for the heaviest recent activity, with the Texas Health and Human Services Commission issuing two substantial IFBs between March and May 2026 for hemoglobin testing systems and ICP-MS consumables; the University of Wisconsin-Madison posted a competitive bid RFB in April 2026 for hematology and whole blood chemistry proficiency testing samples. The Texas HHSC's May 2026 D-10 Hemoglobin Testing System procurement (Solicitation HHS0017310, IFB, due May 18, 2026) sought one compact analyzer unit with automated rack loader capable of processing up to 50 samples, with historical spend guidance of $45,050 to $80,000 for similar equipment in fiscal year 2025; firm fixed pricing and no substitutions without prior written approval are required. The Texas HHSC's earlier March 2026 PerkinElmer ICP-MS consumables procurement (Solicitation HHS0017071, IFB, due March 5, 2026) covered 20 line items of supplies and replaceable parts for pediatric blood lead screening, with historical spend guidance of $20,000 to $30,000. Both Texas solicitations noted that HUB subcontracting plans are encouraged but not required, and neither carries formal disadvantaged-enterprise set-asides.